https://seekingalpha.com/article/4663654-nnn-reit-rare-dividendvalue-pick-stock?source=feed_all_articles
Jan 18, 2024 - NNN REIT stands out from the pack due to its profitability, conservative capitalization, and strong liquidity. Click here to see why NNN stock is a Buy.
0
sa:4315048262764677398
0
https://www.nrn.com/fast-casual/paris-baguette-fills-out-c-suite-promotion-5-new-executives
Jan 18, 2024 - The new leaders finish the restaurant’s C-suite that CEO Darren Tipton has sought to fill since his appointment in 2020
0
nrn:-7413946409483438885
0
https://seekingalpha.com/article/4663600-iyf-a-rotation-out-of-tech-alongside-steepening-yield-curve-helps?source=feed_tag_etf_portfolio_strategy
Jan 18, 2024 - iShares U.S. Financials ETF offers a low-risk and diversified exposure to the Financials sector. Read more to see an overview and analysis of IYF.
0
sa:-6297690170610744504
0
https://seekingalpha.com/article/4663593-its-time-to-start-loading-up-on-small-cap-stocks?source=feed_tag_etf_portfolio_strategy
Jan 18, 2024 - Vanguard Small-Cap Value Index Fund ETF Shares ETF tracks small cap value stocks and is currently cheap at 10.9x ttm PE ratio. Find out why VBR ETF is a Buy.
0
sa:1366392022874557119
0
https://seekingalpha.com/news/4056155-dermtech-study-finds-melanoma-test-effective-for-all-skin-types?source=feed_sector_healthcare
Jan 18, 2024 - DermTech (DMTK) said topline results from a study showed that its melanoma test has a negative predictive value of more than 99% in ruling out the disease across all skin types.
0
sa:2623993396119066794
0
https://seekingalpha.com/article/4663553-my-favorite-spot-bitcoin-etf-none-of-them-hype-versus-technical-analysis-ibit-now-a-bitcoin-indicator?source=feed_tag_etf_portfolio_strategy
Jan 18, 2024 - iShares Bitcoin Trust is worth watching as it has already attracted significant assets and trading volume. Find out why IBIT ETF is a Sell.
0
sa:6865858263199141922
0
https://www.zacks.com/stock/news/2212329/are-you-looking-for-a-top-momentum-pick-why-sana-biotechnology-sana-is-a-great-choice?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2212329
Jan 18, 2024 - Does Sana Biotechnology (SANA) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:-4089975807876436491
0
https://www.zacks.com/stock/news/2212331/are-you-looking-for-a-top-momentum-pick-why-syros-pharmaceuticals-inc-syrs-is-a-great-choice?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2212331
Jan 18, 2024 - Does Syros Pharmaceuticals, Inc. (SYRS) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:-2390223587258330493
0
https://www.zacks.com/stock/news/2212290/is-it-a-good-idea-to-invest-in-intellia-ntla-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2212290
Jan 18, 2024 - Here, we discuss some reasons why investing in Intellia (NTLA) stock now may turn out to be a more prudent move than ever.
zc:6966983953777213566
0
https://www.zacks.com/stock/news/2212231/here-s-why-you-should-invest-in-avadel-avdl-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2212231
Jan 18, 2024 - Here, we discuss some reasons why buying Avadel Pharmaceuticals (AVDL) stock now may turn out to be a prudent move.
zc:1371741271837818172
0